VITAMIN C01
Liposomal Vitamin C
Liquid system for teams screening a liposomal Vitamin C route in new formulation concepts.
- SAP specification
- 9-11%
- Documented batch
- 10.1%
- pH
- 6-9
- Particle size
- 300-900 nm
ACTIVE PRODUCT PROGRAM / FORMULATION R&D
Liposomal vitamin systems
Liquid Vitamin C and Vitamin C + E systems for specification review, batch-document evaluation and formulation trials.
- Format
- Liquid liposomal systems
- Portfolio
- Vitamin C / Vitamin C + E
- Documentation
- Specification and current batch data
- Evaluation
- Formulation R&D and supplement concepts
01
SYSTEM COMPARISON
Choose by formulation need and documented composition.
VITAMIN C + E02
Liposomal Vitamin C + E
Combined liquid system for concepts requiring documented Vitamin C and Vitamin E parameters.
- SAP specification
- 9-11% / batch 10.2%
- Vitamin E
- 0.3-0.5% / batch 0.41%
- pH
- 6-9
- Particle size
- 300-900 nm
Batch values are technical-screening references, not standing guarantees. Confirm composition, test methods and acceptance limits against the current specification and batch COA before qualification.
02
QUALITY REVIEW
What the current technical review covers.
Active parameters
SAP and, for the combined system, Vitamin E are reviewed against the relevant specification and current batch documentation.
pH and particle size
The documented pH and particle-size ranges provide a starting point; the customer verifies process and formulation fit.
Analytical controls
Heavy-metal parameters and microbiological testing are included, with E. coli and Salmonella reported as negative in the referenced documentation.
A soy-lecithin basis is stated only where supported by the current product documentation. The referenced C + E COA includes “(FeCl3)” in the product name; its composition and relevance require confirmation in the current producer documentation before qualification. No absorption, bioavailability or encapsulation-efficiency claim is implied.
03
QUALIFICATION PATH
Move from concept to a controlled formulation trial.
- 01
Define the formulation
Share the product format, target market, processing conditions and required active profile.
- 02
Review current documents
Helbeto coordinates the relevant specification, SDS and available batch COA for technical review.
- 03
Evaluate an R&D sample
Your team confirms compatibility, stability, process behavior and the required finished-product performance.
- 04
Confirm commercial fit
MOQ, price, lead time, storage and destination requirements are confirmed for the selected system.
NEXT STEP
Bring us the formulation brief.
Include your dosage form, target market and required Vitamin C or C + E profile. We will start with the relevant current documents and trial pathway.